Muren, Olle, et al. “No Effect of Risedronate on Femoral Periprosthetic Bone Loss Following Total Hip Arthroplasty”. Acta Orthopaedica, vol. 86, no. 5, Sept. 2015, pp. 569-74, doi:10.3109/17453674.2015.1041846.